Atypical PKCι as Target for Glioblastoma Therapy

E-ISSN： 1873-5576|15|2|136-144

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.15, Iss.2, 2015-02, pp. : 136-144

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Receptor protein tyrosine phosphatase ζ as a therapeutic target for glioblastoma therapy

By Müller Sabine Lamszus Katrin Nikolich Karoly Westphal Manfred

Expert Opinion on Therapeutic Targets, Vol. 8, Iss. 3, 2004-06 ,pp. : 211-220

Informa Healthcare

Access to resources Recommend Favorite

Transforming Growth Factor-&bgr;: A Molecular Target for the Future Therapy of Glioblastoma

Current Pharmaceutical Design, Vol. 12, Iss. 3, 2006-01 ,pp. : 341-349

Bentham Science Publishers

Access to resources Recommend Favorite

PKCη as a therapeutic target in glioblastoma multiforme

By Martin Patrick M Hussaini Isa M

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 2, 2005-04 ,pp. : 299-313

Informa Healthcare

Access to resources Recommend Favorite

Boron neutron capture therapy for glioblastoma multiforme

By Rij Catharina Wilhelm Abraham Sauerwein Wolfgang Loenen Arie

Pharmacy World and Science, Vol. 27, Iss. 2, 2005-04 ,pp. : 92-95

Springer Publishing Company

Access to resources Recommend Favorite

Is Vascular Stiffness a Target for Therapy?

By Duprez Daniel

Cardiovascular Drugs and Therapy, Vol. 24, Iss. 4, 2010-08 ,pp. : 305-310

Springer Publishing Company

Access to resources Recommend Favorite